WS-12, also known as Acoltremon, is a selective serotonin reuptake inhibitor within the cyclohexanecarboxamide class, indicated for the treatment of major depressive disorder and obsessive-compulsive disorder.… Read more
WS-12, also known as Acoltremon, is a selective serotonin reuptake inhibitor within the cyclohexanecarboxamide class, indicated for the treatment of major depressive disorder and obsessive-compulsive disorder. This category provides essential pharmaceutical reference standards, including the parent compound and its stable isotope labelled versions such as WS-12-13C-d3, which are critical for rigorous analytical testing. Pharmaceutical laboratories rely on these high-quality reference materials to support accurate impurity profiling, method validation, and stability testing throughout the drug development lifecycle. By utilizing these precisely characterized compounds, researchers can ensure quantitative accuracy in bioanalytical assays and maintain strict quality control standards. Whether conducting routine quality checks or complex degradation studies, these reference materials serve as vital tools for characterizing the chemical profile of this therapeutic agent and ensuring regulatory compliance in pharmaceutical manufacturing environments.